| Literature DB >> 8249433 |
Abstract
The protective efficacy of mucosal immunization with purified respiratory syncytial virus (RSV) fusion protein (F) using cholera toxin (CT) as an adjuvant was assessed in mice. Intranasal vaccination with F+CT induced F-specific serum IgG and nasal IgA and resulted in 75% protection from nasal virus replication compared with control mice. Intranasal CT+F with simultaneous parenteral F provided complete protection equivalent to intranasal live virus immunization.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8249433 DOI: 10.1016/0264-410x(93)90075-9
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641